CIBERER

CIBERER aims to develop high quality cooperative and innovative research into Rare Diseases, fostering the transfer of results to clinical practice. The specific objectives are mainly based on the development of new treatments and improving access to diagnosis of RDs.

To face this challenge the CIBERER is working in close cooperation with all the agents involved in the field of RD nationally and internationally to:

• Establish and provide access to data, standardised relevant information in RD.
• Carry out molecular and clinical characterisation of RD.
• Further translational, preclinical and clinical research into RD.
• Rationalise the ethical procedures and rules in RD.

For these purposes the lines of action on which work has been done over these years of its existence will be maintained: networking, excellence research, collaborative and cooperative research, translation and transfer of results, as well as the social conspicuousness of RD. As a complement we will also continue to back the internationalisation of research, effective relations with the production sector and institutional visibility.